ArticleEMBO molecular medicine2019

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Sofie Mohlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.